Ulcerative colitis trials in Latvia

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis

  Where

  Liepaja, Riga

  Age

  18 years and over

  People

  587 worldwide

  Run by

  Eli Lilly & Co.

  See details and how to join2023-507853-13-00 · EU 2023-507853-13-00
• Phase 2Taking people
  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  Where

  Riga

  Age

  18 years to 80 years

  People

  1,431 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07415044
• Phase 2Taking people
  A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)

  Where

  Riga

  Age

  18 years and over

  People

  104 worldwide

  Run by

  Eli Lilly & Co.

  See details and how to join2025-524404-29-00 · EU 2025-524404-29-00
• Phase 2Taking people
  A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  Where

  Liepāja, Riga

  Age

  18 years to 75 years

  People

  204 worldwide

  Run by

  Palisade Bio

  See details and how to joinNCT07845487